...
首页> 外文期刊>Leukemia >Recombinant human erythropoietin induces intussusceptive microvascular growth in vivo
【24h】

Recombinant human erythropoietin induces intussusceptive microvascular growth in vivo

机译:重组人促红细胞生成素在体内诱导肠套叠微血管生长

获取原文
           

摘要

The role of erythropoietin (Epo) in angiogenesis has not been completely clarified. Epo induces endothelial cell proliferation and migration and stimulates angiogenesis on rat aortic rings in vitro and in vivo in the chick embryo chorioallantoic membrane (CAM) assay. The aim of the present study was to evaluate the ultrastructural aspects of angiogenesis in the CAM vasculature after recombinant human Epo (rHuEpo) exposure. The results demonstrated that after rHuEpo stimulation, the generation of new blood vessels occurred more frequently following an intussusceptive microvascular growth (IMG) mechanism. We have performed our experiments between days 8 and 12 of incubation, that is, when in the normal condition the capillary network expands mainly by IMG, and because it is generally accepted that implants made from days 8 to 10 are strongly angiogenic. This response is peculiar of rHuEpo, because it is abolished when an Epo-blocking antibody was coadministered with Epo.
机译:促红细胞生成素(Epo)在血管生成中的作用尚未完全阐明。 Epo在鸡胚绒膜尿囊膜(CAM)分析中体外和体内诱导大鼠主动脉环上的内皮细胞增殖和迁移,并刺激血管生成。本研究的目的是评估重组人Epo(rHuEpo)暴露后CAM脉管系统中血管新生的超微结构方面。结果表明,在rHuEpo刺激后,随着肠套叠微血管生长(IMG)机制,新血管的产生更加频繁。我们已经在孵育的第8天到第12天之间进行了实验,也就是说,在正常情况下,毛细血管网主要是由IMG扩张的,并且因为人们普遍认为第8天到第10天制成的植入物具有强烈的血管生成作用。该反应是rHuEpo特有的,因为当Epo阻断抗体与Epo共同施用时,它会被取消。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号